MDT

100.58

-1.14%↓

A

134.59

-3.4%↓

VEEV

221.73

-1.03%↓

HQY

84.73

-2.01%↓

NEOG

9.73

-2.41%↓

MDT

100.58

-1.14%↓

A

134.59

-3.4%↓

VEEV

221.73

-1.03%↓

HQY

84.73

-2.01%↓

NEOG

9.73

-2.41%↓

MDT

100.58

-1.14%↓

A

134.59

-3.4%↓

VEEV

221.73

-1.03%↓

HQY

84.73

-2.01%↓

NEOG

9.73

-2.41%↓

MDT

100.58

-1.14%↓

A

134.59

-3.4%↓

VEEV

221.73

-1.03%↓

HQY

84.73

-2.01%↓

NEOG

9.73

-2.41%↓

MDT

100.58

-1.14%↓

A

134.59

-3.4%↓

VEEV

221.73

-1.03%↓

HQY

84.73

-2.01%↓

NEOG

9.73

-2.41%↓

Search

Cencora Inc

Open

SectorHealthcare

351.8 -0.59

Overview

Share price change

24h

Current

Min

347.68

Max

353.92

Key metrics

By Trading Economics

Income

-1B

-340M

Sales

3.1B

84B

P/E

Sector Avg

44.635

89.037

EPS

3.84

Dividend yield

0.62

Profit margin

-0.406

Employees

47,000

EBITDA

-1.1B

183M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.08% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.62%

2.18%

Next Earnings

4 Feb 2026

Next Dividend date

2 Mar 2026

Next Ex Dividend date

13 Feb 2026

Market Stats

By TradingEconomics

Market Cap

2.7B

69B

Previous open

352.39

Previous close

351.8

News Sentiment

By Acuity

17%

83%

30 / 360 Healthcare

Cencora Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Jan 2026, 21:55 UTC

Earnings

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 Jan 2026, 23:52 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 Jan 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 Jan 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 Jan 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 Jan 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 Jan 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 Jan 2026, 22:37 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 Jan 2026, 21:59 UTC

Acquisitions, Mergers, Takeovers

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 Jan 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

22 Jan 2026, 21:44 UTC

Earnings

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 Jan 2026, 21:32 UTC

Acquisitions, Mergers, Takeovers

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 Jan 2026, 21:31 UTC

Acquisitions, Mergers, Takeovers

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 Jan 2026, 21:31 UTC

Acquisitions, Mergers, Takeovers

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 Jan 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 Jan 2026, 21:30 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 Jan 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Capital One To Acquire Brex >COF

22 Jan 2026, 21:13 UTC

Earnings

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 Jan 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 Jan 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 Jan 2026, 21:10 UTC

Earnings

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 Jan 2026, 21:06 UTC

Earnings

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q Rev $15.58B >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q EPS $3.26 >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q Net Interest Margin 8.26% >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q Net $2.13B >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q Adj EPS $3.86 >COF

22 Jan 2026, 21:05 UTC

Earnings

Capital One 4Q Net Charge-Offs $3.8B >COF

22 Jan 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q EPS $2.21 >ISRG

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

16.08% upside

12 Months Forecast

Average 408.3 USD  16.08%

High 440 USD

Low 371 USD

Based on 11 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Sentiment

By Acuity

30 / 360 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat